Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Safety considerations for nucleic acid vaccines

J S Robertson1

  • 1National Institute for Biological Standards and Control, Herts, UK.

Vaccine
|December 1, 1994
PubMed
Summary

This paper discusses potential safety concerns for DNA vaccines, including tumorigenic events, anti-DNA antibodies, and long-term antigen expression, to inform future biotherapeutic development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of the nuclear reactor for neutron capture therapy of cancer.

Medical sciences (London, England)·2014
Same author

Changes in nonstructural protein 3 are associated with attenuation in avian coronavirus infectious bronchitis virus.

Virus genes·2011
Same author

Assuring the quality, safety, and efficacy of DNA vaccines.

Methods in molecular medicine·2011
Same author

Dissecting aneurysm of the aorta.

Proceedings. Royal Australasian College of Physicians·2010
Same author

Bovine serum--regulatory issues.

Developments in biologicals·2006
Same author

Changes in biological source material.

Biologicals : journal of the International Association of Biological Standardization·2005

Area of Science:

  • Biotechnology
  • Immunology
  • Vaccinology

Background:

  • Nucleic acid vaccines represent a novel biotherapeutic approach.
  • Manufacturing guidelines are premature, but safety discussions are crucial.

Purpose of the Study:

  • To examine the safety implications of DNA vaccines.
  • To address potential risks associated with novel biotherapeutics.

Main Methods:

  • Literature review and critical analysis of existing data.
  • Examination of theoretical safety concerns.

Main Results:

  • Identified key safety issues: potential for transformation (tumorigenic events).
  • Potential for anti-DNA antibody formation.
  • Concerns regarding long-term foreign antigen expression.

Conclusions:

  • These safety issues require careful consideration for DNA vaccine development.
  • Proactive discussion of safety is essential for novel biotherapeutics.

Related Experiment Videos